Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Karius Raises $100M Co-Led by Khosla Ventures, 5AM Ventures and Gilde Healthcare, to Expand Access to Advanced Genomic Diagnostics in Infectious Disease, Addressing Antimicrobial Resistance Crisis
Read Article
News
2024
2023
Archive
Search news articles
October 4, 2022
Cidara Therapeutics Receives $11.1 Million Milestone Payment from Mundipharma
October 4, 2022
Arvinas Appoints Paul McInulty as Senior Vice President, Regulatory Affairs
September 30, 2022
CinCor Pharma Announces Late-Breaking Presentation of Phase 2 BrigHtn Data for Baxdrostat in Treatment-Resistant Hypertension at the Upcoming 2022 American Heart Association Scientific Sessions
September 30, 2022
scPharmaceuticals Announces Data Presentations at the Heart Failure Society of America 2022 Annual Scientific Meeting
September 28, 2022
Vor Bio Initiates In-house Clinical Manufacturing at Cambridge, MA Headquarters
September 28, 2022
Rallybio Announces Positive Preliminary Results for RLYB212, an anti-HPA-1a Monoclonal Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia
September 27, 2022
Arthur Tzianabos, Ph.D., June Lee, MD, FACCP, and Joseph Loscalzo, MD, PhD Join 5AM Ventures
September 21, 2022
NodThera Announces Positive Phase 1 Study Readouts for the NLRP3 Inflammasome Inhibitors NT-0796 and NT-0249
September 20, 2022
Cidara Therapeutics Announces FDA Acceptance for Priority Review of New Drug Application for Rezafungin for the Treatment of Candidemia and Invasive Candidiasis
September 20, 2022
IDEAYA Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares
« Previous Page
1
…
5
6
7
8
9
…
17
Next Page »